EZ Debride clinical trial results at AAHCM Annual Meeting
Thomas E. Serena M.D. F.A.C.S., founder and medical director of the SerenaGroup family of advanced wound and hyperbaric centers, will present at this fall’s American Academy of Home Care Medicine (AAHCM) virtual meeting (Friday, October 23, 2020). The presentation will center on the results of a recently completed clinical trial on the use of EZ Debride in chronic wounds. The study examined the effectiveness of EZ Debride in the post-acute setting. In addition, it evaluated the ability of EZ Debride to reduce bacterial burden using the MolecuLight procedure (MLiX).